These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2901957)

  • 1. Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure.
    Packer M
    Eur Heart J; 1988 Jun; 9 Suppl H():105-8. PubMed ID: 2901957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1770-7. PubMed ID: 9410998
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy of congestive heart failure. An evaluation of recent advances.
    Alpert MA
    Postgrad Med; 1987 May; 81(6):257-67. PubMed ID: 2883640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we expect vasodilator therapy to prolong life in patients with congestive heart failure?
    Packer M; Lee WH; Kessler PD; Gottlieb SS
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S73-5. PubMed ID: 2441205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hope.
    Packer M
    J Am Coll Cardiol; 1988 Nov; 12(5):1299-317. PubMed ID: 2844873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the treatment of heart failure.
    Cohn JN
    Am J Cardiol; 1997 Dec; 80(11A):2L-6L. PubMed ID: 9412537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors].
    Stefenelli T
    Acta Med Austriaca; 1991; 18(4):81-5. PubMed ID: 1763582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE
    Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.
    Packer M
    Circulation; 1990 Feb; 81(2 Suppl):III78-86. PubMed ID: 1967559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term strategies in the management of heart failure: looking beyond ventricular function and symptoms.
    Packer M
    Am J Cardiol; 1992 Jun; 69(18):150G-154G. PubMed ID: 1626488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exercise test in the evaluation of the efficacy of drug therapy].
    Febo O; Cobelli F
    Ital Heart J Suppl; 2000 Mar; 1(3):393-9. PubMed ID: 10815269
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of vasodilators in the treatment of heart failure.
    Cohn JN
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):135A-138A. PubMed ID: 8376683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vasodilators in heart failure. Basis for their use].
    Mesquita ET; Mady C
    Arq Bras Cardiol; 1994 Dec; 63(6):531-6. PubMed ID: 7605242
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.
    Packer M
    J Am Coll Cardiol; 1983 Nov; 2(5):841-52. PubMed ID: 6138375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.